Publication | Closed Access
Synthesis and topical antiinflammatory activity of some steroidal [16.alpha.,17.alpha.-d]-isoxazolidines
36
Citations
0
References
1982
Year
Therapeutic Drug MonitoringMedicinal ChemistryPharmaceutical SciencePreclinical Drug EvaluationDonut IconMedicineTopical Antiinflammatory ActivityAltmetric Attention ScoreTopical DrugSocial Media PresenceDrug MonitoringPharmacotherapyDrug DevelopmentPharmacologyDrug DiscoveryPre-clinical PharmacologyQuantitative Pharmacology
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTSynthesis and topical antiinflammatory activity of some steroidal [16.alpha.,17.alpha.-d]-isoxazolidinesMichael J. Green, Robert L. Tiberi, Richard Friary, Barry N. Lutsky, Joseph Berkenkoph, Xiomara Fernandez, and Margaret MonahanCite this: J. Med. Chem. 1982, 25, 12, 1492–1495Publication Date (Print):December 1, 1982Publication History Published online1 May 2002Published inissue 1 December 1982https://pubs.acs.org/doi/10.1021/jm00354a020https://doi.org/10.1021/jm00354a020research-articleACS PublicationsRequest reuse permissionsArticle Views354Altmetric-Citations30LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts